Health


 How Eli Lilly (NYSE:LLY) Is Expanding Its Pharmaceutical Leadership

How Eli Lilly (NYSE:LLY) Is Expanding Its Pharmaceutical Leadership

January 23, 2025 08:11 AM PST| By Team Kalkine Media

Highlights,Eli Lilly achieved a 20.4% revenue growth year-over-year in Q3.,Earnings per share (EPS) fell below expectations for the quarter.,Innovative treatments for diabetes and obesity remain central to its portfolio.,Eli Lilly continues to be a s...

 Why Is ANGLE PLC's 2025 Outlook Generating Buzz in the Biotech Sector?

Why Is ANGLE PLC's 2025 Outlook Generating Buzz in the Biotech Sector?

January 23, 2025 04:49 AM PST| By Team Kalkine Media

Highlights,ANGLE PLC focuses on liquid biopsy technologies, reporting a strengthened sales pipeline and improved financial stability.,Revenue growth for the current year is projected to exceed the previous year's increase of over thirty percent.,Stra...

 Disc Medicine (NASDAQ: IRON) Announces Upsized Public Offering, Raising $225.5 Million to Support Clinical Development

Disc Medicine (NASDAQ: IRON) Announces Upsized Public Offering, Raising $225.5 Million to Support Clinical Development

January 23, 2025 04:02 AM PST| By Team Kalkine Media

Highlights,Disc Medicine raises $225.5 million in upsized public offering of common stock and warrants.,Funds will support research, clinical development, and commercialization of bitopertin for EPP and XLP.,Offering led by Jefferies, Leerink Partner...

 Zai Lab (NASDAQ: ZLAB; HKEX: 9688) Receives FDA Orphan Drug Designation for ZL-1310 in Small Cell Lung Cancer (SCLC)

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) Receives FDA Orphan Drug Designation for ZL-1310 in Small Cell Lung Cancer (SCLC)

January 23, 2025 03:45 AM PST| By Team Kalkine Media

Highlights,Zai Lab’s ZL-1310 gains Orphan Drug Designation from the U.S. FDA for SCLC.,Promising Phase 1 trial results demonstrate strong potential for ZL-1310.,Drug eligible for significant market and financial benefits under FDA ODD.,Zai Lab (NASDA...

 Teladoc Health Sees Surge in Options Activity (NYSE:TDOC)

Teladoc Health Sees Surge in Options Activity (NYSE:TDOC)

January 22, 2025 11:22 PM PST| By Team Kalkine Media

Headlines,Unusually High Options Volume for Teladoc Health,Insider Sells Shares Amid Activity Surge,Institutional Investors Increase Stake in TDOC,Teladoc Health Sees Surge in Options Activity,Teladoc Health, Inc.,(NYSE:TDOC),has witnessed an unexpec...

 CVS Health Sees Surge in Options Trading Activity (NYSE:CVS)

CVS Health Sees Surge in Options Trading Activity (NYSE:CVS)

January 22, 2025 10:57 PM PST| By Team Kalkine Media

Headlines,Surge in CVS Health Call Option Trading Volumes,Institutional Investors Adjust CVS Health Holdings,CVS Health Reports Solid Earnings Despite Market Shifts,CVS Health Draws Attention in Options Market,CVS Health Co. (NYSE:CVS) experienced a...

 How UnitedHealth Group (NYSE:UNH) Maintains Strong Fundamentals

How UnitedHealth Group (NYSE:UNH) Maintains Strong Fundamentals

January 22, 2025 08:57 AM PST| By Team Kalkine Media

Highlights,UnitedHealth Group maintains a 17% return on capital employed.,Capital employed has grown by 74% over five years.,Strong fundamentals have driven a 98% return for shareholders.,UnitedHealth Group Incorporated has demonstrated consistent re...

 McKesson Corporation (NYSE:MCK)  Shareholder Power and Influence

McKesson Corporation (NYSE:MCK) Shareholder Power and Influence

January 22, 2025 08:43 AM PST| By Team Kalkine Media

Highlights,Institutions hold 89% of McKesson Corporation .,The Vanguard Group holds the largest stake at 9.5%.,Top 21 shareholders control over 50% of McKesson’s shares.,McKesson Corporation, a key player in the healthcare sector, is predominantly he...

 Thermo Fisher Scientific's (TMO) Institutional Investor Activity

Thermo Fisher Scientific's (TMO) Institutional Investor Activity

January 22, 2025 04:48 AM PST| By Team Kalkine Media

Headlines,New Institutional Investments in Thermo Fisher Scientific,Institutional Ownership Remains Strong in TMO,Bedrijfstakpensioenfonds reduces stake but retains significant position.,Thermo Fisher Scientific (NYSE:TMO),has witnessed notable activ...

 Clear Harbor Asset Management Increases AbbVie (NYSE:ABBV) Stake

Clear Harbor Asset Management Increases AbbVie (NYSE:ABBV) Stake

January 22, 2025 04:38 AM PST| By Team Kalkine Media

Headlines,Clear Harbor Expands AbbVie Position,Institutional Investors Boost AbbVie Holdings,Hedge Funds Maintain Strong Control of AbbVie Shares,Clear Harbor Asset Management Expands AbbVie Holdings,Clear Harbor Asset Management LLC has increased it...

 Eli Lilly (NYSE:LLY) Faces Drop – What's Ahead for the Pharma Giant?

Eli Lilly (NYSE:LLY) Faces Drop – What's Ahead for the Pharma Giant?

January 22, 2025 04:07 AM PST| By Team Kalkine Media

Headlines,Eli Lilly Shares Experience a Decline,Key Analyst Activity and Ratings for LLY,What's Next for Eli Lilly's Stock?,Eli Lilly (NYSE:LLY) Faces Market Movement - What's Next?,Shares of Eli Lilly and Company,(NYSE:LLY),saw a notable decrease re...

 Medtronic (NYSE:MDT) Sees Significant Stake Increases from Key Investors

Medtronic (NYSE:MDT) Sees Significant Stake Increases from Key Investors

January 22, 2025 03:24 AM PST| By Team Kalkine Media

Headlines,Ballentine Partners LLC Expands Medtronic Stake,Notable Institutional Investors Boost Holdings in MDT,Medtronic Sees Growth Amidst Increased Investment,Medtronic Sees Surge in Institutional Investment,Medtronic plc,(NYSE:MDT),has witnessed...

 Expanded Holdings in NYSE:MRK by Institutions

Expanded Holdings in NYSE:MRK by Institutions

January 22, 2025 03:05 AM PST| By Team Kalkine Media

Headlines,Increased institutional activity surrounding,NYSE:MRK.,Perpetual Ltd significantly expands its stake.,Broader trends among major investment firms observed.,Institutional Focus on Merck & Co., Inc.,Perpetual Ltd has made a significant adjust...

 Xilio Therapeutics (Nasdaq: XLO) Reports Promising Initial Phase 2 Data for Vilastobart (XTX101) in MSS CRC Treatment

Xilio Therapeutics (Nasdaq: XLO) Reports Promising Initial Phase 2 Data for Vilastobart (XTX101) in MSS CRC Treatment

January 21, 2025 09:12 PM PST| By Team Kalkine Media

Highlights,27% preliminary response rate observed in metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases.,Combination of vilastobart (XTX101) and atezolizumab shows favorable safety profile with low immune-related ad...

 Ainos (NASDAQ: AIMD) Receives Positive Water Tower Research Report on AI Nose Technology and Strategic Milestones

Ainos (NASDAQ: AIMD) Receives Positive Water Tower Research Report on AI Nose Technology and Strategic Milestones

January 21, 2025 08:34 PM PST| By Team Kalkine Media

Highlights,Ainos’ AI Nose technology shows strong progress in robotics, smart manufacturing, elderly care, and women’s health.,VOC sensing program in semiconductor factories achieves 80% accuracy, with mass production set for 1H2025.,Ainos Flora devi...

 Biohaven Ltd. (NYSE:BHVN): Strategic Progress and Industry Outlook

Biohaven Ltd. (NYSE:BHVN): Strategic Progress and Industry Outlook

January 21, 2025 09:29 AM PST| By Team Kalkine Media

Headlines,Biohaven Ltd. (NYSE:BHVN) receives strong endorsements from research firms.,Positive outlook with increased ratings and revised price targets.,Continued focus on innovative healthcare solutions.,Biohaven Ltd. has garnered significant attent...

 What Factors Are Driving Cencora’s Stock Performance?

What Factors Are Driving Cencora’s Stock Performance?

January 21, 2025 02:10 AM PST| By Team Kalkine Media

Highlights:,Cencora's stock opens at $242.11 with a 0.5% increase.,The company maintains a market capitalization of $46.80 billion.,Key financial ratios reflect stability and growth prospects.,The healthcare and pharmaceutical distribution sector pla...

 Encompass Health Sees Notable Growth in Short Interest

Encompass Health Sees Notable Growth in Short Interest

January 21, 2025 12:02 AM PST| By Team Kalkine Media

Headlines,Short interest in Encompass Health increases significantly,Positive analyst outlook drives company’s performance,High levels of short interest could impact trading,Encompass Health Co.,(NYSE:EHC),recently experienced a significant increase...

 Quest Diagnostics: Insights on Short Interest Trends

Quest Diagnostics: Insights on Short Interest Trends

January 20, 2025 11:32 PM PST| By Team Kalkine Media

Headlines,Rising Short Interest in Quest Diagnostics,Performance Metrics Highlight Recent Developments,Earnings and Revenue Showcase Resilience,Quest Diagnostics Short Interest and Performance Overview,Quest Diagnostics,(NYSE:DGX),has observed an inc...

 Growing Focus on ADC Therapeutics (NYSE:ADCT)

Growing Focus on ADC Therapeutics (NYSE:ADCT)

January 20, 2025 10:19 PM PST| By Team Kalkine Media

Headlines,Short Interest Sees Notable Rise in December for ADC Therapeutics,Insider Activity Highlights Strategic Stock Movements,Key Financial Trends Signal ADC Therapeutics' Developments,Rising Interest in ADC Therapeutics: Key Updates,ADC Therapeu...

Recent Articles






Investing Tips

Previous Next